5-Sulfonyl-1-Piperidinyl Substituted Indole Derivatives as 5-Ht6 Receptor Antagonists for the Treatment of Cns Disorders
申请人:Ahmed Mahmood
公开号:US20080318933A1
公开(公告)日:2008-12-25
The present invention relates to novel indole derivatives such as compounds of the formula (I):
which possess antagonist potency at the 5-HT
6
receptor and the use of such compounds or pharmaceutically acceptable salts or solvates thereof in the treatment of Alzheimer's disease and other CNS disorders.
Synthesis of 18F‐labeled Aryl Trifluoromethyl Sulfones, ‐Sulfoxides, and ‐Sulfides for Positron Emission Tomography
作者:Lukas Veth、Albert D. Windhorst、Danielle J. Vugts
DOI:10.1002/anie.202404278
日期:2024.7
The mild and high-yielding synthesis of 18F-labeled aryl trifluoromethyl sulfones, -sulfoxides, and -sulfides using [18F]Ruppert-Prakash reagent is described. The application to the radiolabeling of different bioactive compounds using >1 GBq of 18F-labeling reagent is demonstrated. This work expands the radiochemical space of [18F]CF3-containing structural motifs for the use in positron emission tomography
Triaryl bis-sulfones as cannabinoid-2 receptor ligands: SAR studies
作者:Bandarpalle B. Shankar、Brian J. Lavey、Guowei Zhou、James A. Spitler、Ling Tong、Razia Rizvi、De-Yi Yang、Ronald Wolin、Joseph A. Kozlowski、Neng-Yang Shih、Jie Wu、R. William Hipkin、Waldemar Gonsiorek、Charles A. Lunn
DOI:10.1016/j.bmcl.2005.07.023
日期:2005.10
We recently reported that compound 1 is a potent inhibitor of the CB2 receptor with high selectivity over CB1. This paper describes the SAR development for this class of compounds. Variation of the substitution pattern on the aromatic rings, as well as the groups linking them together, led to sub-nanomolar inhibitors of the CB2 receptor, with high selectivity over CB1. (c) 2005 Elsevier Ltd. All rights reserved.
Hydrosulfonylation of Unactivated Alkenes and Alkynes by Halogen-Atom Transfer (XAT) Cleavage of S<sup>VI</sup>–F Bond
作者:Xing Wu、Bing Gao
DOI:10.1021/acs.orglett.3c03628
日期:2023.12.8
5-SULFONYL-1-PIPERIDINYL SUBSTITUTED INDOLE DERIVATIVES AS 5-HT6 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF CNS DISORDERS